Metformin Pharmacogenomics: Current Status and Future Directions

The incidence of type 2 diabetes (T2D) and its costs to the health care system continue to rise. Despite the availability of at least 10 drug classes for the treatment of T2D, metformin remains the most widely used first-line pharmacotherapy for its treatment; however, marked interindividual variabi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pawlyk, Aaron C., Giacomini, Kathleen M., McKeon, Catherine, Shuldiner, Alan R., Florez, Jose C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2014
Materias:
Perspectives in Diabetes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113063/
https://www.ncbi.nlm.nih.gov/pubmed/25060887
http://dx.doi.org/10.2337/db13-1367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113063/
https://www.ncbi.nlm.nih.gov/pubmed/25060887
http://dx.doi.org/10.2337/db13-1367

Ejemplares similares